COVID-19 and Anemia: What Do We Know So Far?

Area of Science:

• Hematology
• Infectious Diseases
• Critical Care Medicine

Background:

• The World Health Organization declared SARS-CoV-2 (causing COVID-19) a global pandemic in March 2020.
• COVID-19 primarily affects the respiratory system but also causes hematological pathologies, including anemia.
• Anemia, a condition of reduced red blood cell oxygen-carrying capacity, is linked to severe COVID-19 cases.

Purpose of the Study:

• To review the evidence on long-term COVID-19 complications in anemic patients.
• To understand how anemia influences COVID-19 severity and patient prognosis.
• To explore the pathophysiological mechanisms linking anemia and severe SARS-CoV-2 infection.

Main Methods:

• Comprehensive literature review of existing research.
• Analysis of studies investigating COVID-19 in anemic populations.
• Synthesis of evidence on hematological, thrombotic, hemorrhagic, and autoimmune factors.

Main Results:

• Anemic individuals are at increased risk for severe COVID-19.
• Pathophysiological mechanisms include thrombotic, hemorrhagic, and autoimmune factors.
• Reduced hemoglobin levels exacerbate COVID-19-induced hypoxia and ARDS.

Conclusions:

• Anemia significantly increases the risk and severity of COVID-19.
• Understanding these complications is crucial for predicting patient prognosis.
• Further research is needed to elucidate long-term outcomes in anemic COVID-19 patients.